GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a significant focus in therapeutic research, largely due to its remarkable impact on treating ailments such as type 2 diabetes and obesity. Recent research have shown that more than glucose regulation, GLP-1 drugs of